#81, Thinking Big to Improve Liver Disease Outcomes, Quin Wills from Ochre Bio
Listen now
Description
Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.
More Episodes
Mendel enables life sciences to index patient journeys at scale and learn from them at the speed of real-time dialogues. The journey started in 2017 from a two-person office in Silicon Valley with commitment to building novel technology and not to be another “Boy Who Cried Wolf” AI company. To do...
Published 05/21/24
Published 05/21/24
Vivodyne, a biotech firm employing bottom-up self-assembly principles to grow complex tissues that better mimic human physiology, enabling the study of systemic effects like immune responses and linking multiple tissue systems.
Published 05/14/24